These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15354333)

  • 1. Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory.
    Strom CM; Crossley B; Redman JB; Quan F; Buller A; McGinniss MJ; Sun W
    Genet Med; 2004; 6(3):145-52. PubMed ID: 15354333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities.
    Hoffman JD; Park JJ; Schreiber-Agus N; Kornreich R; Tanner AK; Keiles S; Friedman KJ; Heim RA
    Prenat Diagn; 2014 Dec; 34(12):1161-7. PubMed ID: 24996053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
    Kornreich R; Ekstein J; Edelmann L; Desnick RJ
    Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population.
    Ekstein J; Rubin BY; Anderson SL; Weinstein DA; Bach G; Abeliovich D; Webb M; Risch N
    Am J Med Genet A; 2004 Aug; 129A(2):162-4. PubMed ID: 15316959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendation of premarital genetic screening in the Syrian Jewish community based on mutation carrier frequencies within Syrian Jewish cohorts.
    Zeevi DA; Chung WK; Levi C; Scher SY; Bringer R; Kahan Y; Muallem H; Benel R; Hirsch Y; Weiden T; Ekstein A; Ekstein J
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1756. PubMed ID: 34288589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pan-ethnic and ethnic-based carrier screening panels for individuals of Ashkenazi Jewish descent.
    Rosenblum LS; Zhu H; Zhou Z; Teicher J; Heim RA; Leach NT
    J Genet Couns; 2020 Feb; 29(1):56-66. PubMed ID: 31663226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent.
    Strom CM; Janeczko RA; Anderson B; Redman J; Quan F; Buller A; McGinniss MJ; Sun WM
    Genet Med; 2005; 7(9):633-9. PubMed ID: 16301865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal genetic screening in the Ashkenazi Jewish population.
    Zinberg RE; Kornreich R; Edelmann L; Desnick RJ
    Clin Perinatol; 2001 Jun; 28(2):367-82. PubMed ID: 11499058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing.
    Klugman S; Schreiber-Agus N; Nazareth S; Evans EA
    Genet Test Mol Biomarkers; 2013 Oct; 17(10):763-7. PubMed ID: 23952016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews.
    Lehavi O; Aizenstein O; Bercovich D; Pavzner D; Shomrat R; Orr-Urtreger A; Yaron Y
    Genet Test; 2003; 7(2):139-42. PubMed ID: 12885336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay.
    Feigenbaum A; Moore R; Clarke J; Hewson S; Chitayat D; Ray PN; Stockley TL
    Am J Med Genet A; 2004 Jan; 124A(2):142-7. PubMed ID: 14699612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian diseases among Roman Jews: implications for the origins of disease alleles.
    Oddoux C; Guillen-Navarro E; Ditivoli C; Dicave E; Cilio MR; Clayton CM; Nelson H; Sarafoglou K; McCain N; Peretz H; Seligsohn U; Luzzatto L; Nafa K; Nardi M; Karpatkin M; Aksentijevich I; Kastner D; Axelrod F; Ostrer H
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4405-9. PubMed ID: 10599695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.